Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 1
1992 1
1993 1
1997 7
1998 1
1999 1
2001 4
2002 4
2003 3
2004 9
2006 3
2007 2
2008 6
2009 1
2011 2
2012 1
2014 1
2015 3
2016 2
2017 1
2018 8
2019 2
2020 4
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

67 results
Results by year
Filters applied: . Clear all
Page 1
Renoprotective Effects of Additional SGLT2 inhibitor Therapy in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3b-4: A Real World Report From A Japanese Specialized Diabetes Care Center.
Sugiyama S, Jinnouchi H, Yoshida A, Hieshima K, Kurinami N, Jinnouchi K, Tanaka M, Suzuki T, Miyamoto F, Kajiwara K, Jinnouchi T. Sugiyama S, et al. Among authors: hieshima k. J Clin Med Res. 2019 Apr;11(4):267-274. doi: 10.14740/jocmr3761. Epub 2019 Mar 18. J Clin Med Res. 2019. PMID: 30937117 Free PMC article.
Initial Acute Decline in Estimated Glomerular Filtration Rate After Sodium-Glucose Cotransporter-2 Inhibitor in Patients With Chronic Kidney Disease.
Sugiyama S, Yoshida A, Hieshima K, Kurinami N, Jinnouchi K, Tanaka M, Suzuki T, Miyamoto F, Kajiwara K, Jinnouchi T, Jinnouchi H. Sugiyama S, et al. Among authors: hieshima k. J Clin Med Res. 2020 Nov;12(11):724-733. doi: 10.14740/jocmr4351. Epub 2020 Nov 3. J Clin Med Res. 2020. PMID: 33224374 Free PMC article.
The SGLT2 Inhibitor Dapagliflozin Significantly Improves the Peripheral Microvascular Endothelial Function in Patients with Uncontrolled Type 2 Diabetes Mellitus.
Sugiyama S, Jinnouchi H, Kurinami N, Hieshima K, Yoshida A, Jinnouchi K, Nishimura H, Suzuki T, Miyamoto F, Kajiwara K, Jinnouchi T. Sugiyama S, et al. Among authors: hieshima k. Intern Med. 2018 Aug 1;57(15):2147-2156. doi: 10.2169/internalmedicine.0701-17. Epub 2018 Mar 30. Intern Med. 2018. PMID: 29607968 Free PMC article.
Impact of Dapagliflozin Therapy on Renal Protection and Kidney Morphology in Patients With Uncontrolled Type 2 Diabetes Mellitus.
Sugiyama S, Jinnouchi H, Kurinami N, Hieshima K, Yoshida A, Jinnouchi K, Tanaka M, Nishimura H, Suzuki T, Miyamoto F, Kajiwara K, Jinnouchi T. Sugiyama S, et al. Among authors: hieshima k. J Clin Med Res. 2018 Jun;10(6):466-477. doi: 10.14740/jocmr3419w. Epub 2018 Apr 13. J Clin Med Res. 2018. PMID: 29707088 Free PMC article.
Dapagliflozin significantly reduced liver fat accumulation associated with a decrease in abdominal subcutaneous fat in patients with inadequately controlled type 2 diabetes mellitus.
Kurinami N, Sugiyama S, Yoshida A, Hieshima K, Miyamoto F, Kajiwara K, Jinnouch K, Jinnouchi T, Jinnouchi H. Kurinami N, et al. Among authors: hieshima k. Diabetes Res Clin Pract. 2018 Aug;142:254-263. doi: 10.1016/j.diabres.2018.05.017. Epub 2018 May 31. Diabetes Res Clin Pract. 2018. PMID: 29859912
67 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page